66. IgA nephropathy Clinical trials / Disease details

Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00922311 (ClinicalTrials.gov)	July 2009	14/6/2009	Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade	Aliskiren Combined With Losartan in Immunoglobulin A Nephropathy: an Open-label Pilot Study	IgA Nephropathy	Drug: Aliskiren	The University of Hong Kong	Queen Mary Hospital, Hong Kong;United Christian Hospital	Completed	18 Years	70 Years	Both	25	Phase 4	China
2	NCT00863252 (ClinicalTrials.gov)	March 2002	15/3/2009	Mycophenolate Mofetil for IgA Nephropathy	A Prospective, Randomized, Open Label, Case-Controlled Study on the Efficacy of Mycophenolate Mofetil for IgA Nephropathy Patients With Heavy Proteinuria Despite Angiotensin Blockade	IGA Nephropathy	Drug: mycophenolate mofetil;Drug: angiotensin blockade	The University of Hong Kong	United Christian Hospital;Queen Mary Hospital, Hong Kong	Completed	18 Years	70 Years	Both	40	Phase 4	China